Skip to content

Medifast MED Q4 2024 Annual earnings

Reported February 18, 2025 · After market close

Revenue$119.0MBeat by $4.8M
EPS$0.10Beat by $0.26
Revenue estimate$114.3M
EPS estimate-$0.16

Next report

Aug 3, 2026 (Today)
Revenue estimate$72.7M
EPS estimate-$0.65

Financials

Q4 2024

Income statement

See full
Revenue$119.0M-37.7%
Gross profit$88.2M-37.6%
Operating income$709.0K-91.8%
Net income$801.0K-86.7%
EPS (diluted)$0.07-87.3%

Balance sheet

See full
Cash & equivalents$90.9M-3.7%
Total debt$16.1M-26.7%
Total equity$210.1M+4.3%
Total assets$284.2M-8.3%

Cash flow

See full
CapEx$2.3M+142%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$192.72M-73.7%
Enterprise value$117.92M-82.1%
P/E92.1×+84.8×
P/S0.3×-0.4×

Profitability

See full
Gross margin73.8%+1.4pp
Operating margin0.5%-11.3pp
Net margin0.3%-8.9pp

Returns & leverage

See full
Return on equity1%-54.8pp
Debt / equity0.1×0.0×
Current ratio3.3×+0.9×

Segments

By segment

See full
Optavia Segment$119.0M-55.6%

Versus estimates

Ask the moment Medifast reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Medifast report Q4 2024 earnings?
Medifast (MED) reported Q4 2024 earnings on February 18, 2025 after market close.
What were Medifast's Q4 2024 revenue and EPS?
Medifast reported revenue of $119.0M and eps of $0.10 for Q4 2024.
Did Medifast beat estimates in Q4 2024?
Revenue beat the consensus estimate of $114.3M by $4.8M. EPS beat the consensus estimate of $-0.16 by $0.26.
Where can I find Medifast's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001628280-25-006094) directly on SEC EDGAR. The filing index links above go to sec.gov.